ID: ALA3260676

Max Phase: Preclinical

Molecular Formula: C15H14ClNO5

Molecular Weight: 323.73

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)/C=C/CNC(=O)c1cc2cc(Cl)cc(OC)c2o1

Standard InChI:  InChI=1S/C15H14ClNO5/c1-20-11-8-10(16)6-9-7-12(22-14(9)11)15(19)17-5-3-4-13(18)21-2/h3-4,6-8H,5H2,1-2H3,(H,17,19)/b4-3+

Standard InChI Key:  KSHLRGWTOQMMTM-ONEGZZNKSA-N

Associated Targets(non-human)

Human rhinovirus A protease 1343 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 323.73Molecular Weight (Monoisotopic): 323.0561AlogP: 2.55#Rotatable Bonds: 5
Polar Surface Area: 77.77Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.11CX LogD: 2.11
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.68Np Likeness Score: -0.38

References

1. Kathman SG, Xu Z, Statsyuk AV..  (2014)  A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases.,  57  (11): [PMID:24870364] [10.1021/jm500345q]

Source